Third Point Management, a New York-based investment advisor, released its first-quarter 2025 investor letter. Third Point’s flagship Offshore Fund returned -0.6% in Q1 2026. The fund started the quarter strong with gains in semiconductors, memory, equipment, infrastructure, aerospace, and defense. A copy of the letter is available to download here. Despite profits and reducing exposures before the Iran war, it slightly declined but outperformed the S&P by 400bps. Market turmoil arose from the unwinding of private credit, a surge in oil prices due to Iran, and crowding in AI trades became a liability. Weak labor data, a benign CPI, and a steady Fed failed to quell oil-driven inflation fears, raising yields and resetting the expectations for Fed easing. The firm remains cautious about various outcomes based on Iran’s conflict and oil prices impacting rates, inflation, and growth. The short book gained 7% gross and 6.6% net, while the corporate credit book was flat, outperforming the High Yield index, which fell nearly 60bps. In addition, please check the Strategy’s top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Third Point Management highlighted Claritev Corporation (NYSE:CTEV). Claritev Corporation (NYSE:CTEV) is a leading healthcare technology and data analytics company. On April 20, 2026, Claritev Corporation (NYSE:CTEV) closed at $22.45 per share. One-month return of Claritev Corporation (NYSE:CTEV) was 46.25%, and its shares gained 9.83% over the past 52 weeks. Claritev Corporation (NYSE:CTEV) has a market capitalization of $380.91 million.
Third Point Management stated the following regarding Claritev Corporation (NYSE:CTEV) in its Q1 2026 investor letter:
“Claritev Corporation (NYSE:CTEV) was a significant winner for us last year but more recently has come under pressure due to concerns surrounding AI. Claritev is a source of third-party pricing information for insurance companies that need to reimburse out-of-network healthcare providers. The company is also seeking to monetize its extensive pricing and healthcare data trove by providing this information to healthcare providers and corporations that are selecting plans. We believe that Claritev, with its petabytes of data, is on the “right side” of AI and will benefit from rather than be displaced by AI, but we expect it will take a few quarters to prove out.”
Claritev Corporation (NYSE:CTEV) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 13 hedge fund portfolios held Claritev Corporation (NYSE:CTEV) at the end of the fourth quarter, the same as in the previous quarter. While we acknowledge the risk and potential of Claritev Corporation (NYSE:CTEV) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Claritev Corporation (NYSE:CTEV) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
